RxDoctor Payments Data

Miguel Rivera, MD

Pain Medicine · Vero Beach, FLNPI 1316139959

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $52,000 of the $61,691 with a category attached, or 84.3%. Vertos Medical, Inc. accounts for 91.9% of it on its own, with 24 other manufacturers making up the rest. Reporting peaked in 2021 at $27,146 and has fallen 97.8% since, to $607 in 2025. Among pain medicine clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$61,691in general payments, 2019–2025

Across 146 payments — averaging $422.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Vertos Medical, Inc.$57K
  • Spinal Simplicity, LLC$2K
  • Boston Scientific$926
  • Genesys Orthopedics Systems, L.L.C.$738
  • SPR Therapeutics, Inc$425
  • Relievant Medsystems, Inc.$251
  • plus $1K from 19 others

What the payments were for

  • Consulting fees$52,00084%
  • Travel & lodging$3,6336%
  • Food & beverage$6,04410%
  • Gifts$140%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$61,691 in reported general payments places this provider in the 95th percentile of 596 pain medicine providers in Florida.

See all pain medicine providers in Florida

Medicare billing

Part B allowed, 2024
$440,791
Medicare patients
570
Services billed
8,197

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen414$9,840
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen256$9,534
Xtampza ErOxycodone Myristate12$4,475
Oxycodone Hcl77$2,418
Fentanyl12$2,151
Pregabalin65$2,143
Gabapentin169$1,762
Tramadol Hcl230$1,617
Lidocaine13$1,380
Celecoxib51$1,131
Baclofen56$741
Diclofenac Sodium64$731
Morphine Sulfate ErMorphine Sulfate43$697
Tramadol Hcl ErTramadol Hcl12$571
Tizanidine Hcl60$519

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Collegium Pharmaceutical, Inc.Xtampza Er$18$4,47512 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 596 pain medicine providers in Florida.

Other pain medicine in Vero Beach

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →